June 26 brought the CDC’s highest emergency activation for Ebola, elevating the DRC-Uganda outbreak to the agency’s top priority and unlocking staff and resources across the agency.
The move reflects the outbreak’s urgency, scale and complexity, even as the US still has no publicly released plan naming where infected Americans abroad would be treated.
13 federally funded Level 1 special-pathogen treatment centers already operate in the US through NETEC’s national network, and patients on US soil would still be isolated locally before transfer there.
A 50-bed quarantine facility the US backed in Kenya for evacuated Americans has been halted after court action, undercutting the offshore option officials had leaned on.
Risk to the broader US public remains low: a study found just 28 confirmed Ebola cases outside Africa in 50 years, though France reported an imported case on June 24.
Why did the US build a costly pathogen system if its plan is to treat infected Americans abroad?
With its offshore plan collapsed, what is the new protocol for American Ebola patients in Africa?
Bundibugyo Virus Disease in DRC: Escalating 2026 Outbreak, Response Gaps, and Global Preparedness Challenges
Overview
The Democratic Republic of the Congo is facing a rapidly growing outbreak of Bundibugyo virus disease, with sustained transmission and a sharp rise in reported cases as of late June 2026. This situation signals a serious and escalating public health crisis that needs urgent action. The virus is spreading quickly, and current control measures are struggling to keep up. Without effective intervention, the outbreak could expand further, making it harder to contain. The immediate threat is clear: the outbreak is evolving fast, and strong, coordinated responses are needed to prevent wider spread and protect communities.